Biofrontera Inc. Announces Participation in Two Dermatology Conferences in January
10 janv. 2022 08h45 HE
|
Biofrontera Inc.
WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products,...